Jump to content

SLAMF7

From Wikipedia, the free encyclopedia
(Redirected from CD319)
SLAMF7
Identifiers
AliasesSLAMF7, 19A, CD319, CRACC, CS1, SLAM family member 7
External IDsOMIM: 606625; MGI: 1922595; HomoloGene: 49660; GeneCards: SLAMF7; OMA:SLAMF7 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_144539
NM_001347184

RefSeq (protein)

NP_001334113
NP_653122

Location (UCSC)Chr 1: 160.74 – 160.75 MbChr 1: 171.46 – 171.48 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

SLAM family member 7 is a protein that in humans is encoded by the SLAMF7 gene.[5][6][7]

The surface antigen CD319 (SLAMF7) is a robust marker of normal plasma cells and malignant plasma cells in multiple myeloma. In contrast to CD138 (the traditional plasma cell marker), CD319/SLAMF7 is much more stable and allows robust isolation of malignant plasma cells from delayed or even cryopreserved samples.[8]

Elotuzumab is an antibody that targets this protein.

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000026751Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000038179Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Murphy JJ, Hobby P, Vilarino-Varela J, Bishop B, Iordanidou P, Sutton BJ, Norton JD (Feb 2002). "A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion". The Biochemical Journal. 361 (Pt 3): 431–6. doi:10.1042/0264-6021:3610431. PMC 1222324. PMID 11802771.
  6. ^ Boles KS, Mathew PA (Feb 2001). "Molecular cloning of CS1, a novel human natural killer cell receptor belonging to the CD2 subset of the immunoglobulin superfamily". Immunogenetics. 52 (3–4): 302–7. doi:10.1007/s002510000274. PMID 11220635. S2CID 39567095.
  7. ^ "Entrez Gene: SLAMF7 SLAM family member 7".
  8. ^ Frigyesi I, Adolfsson J, Ali M, Christophersen MK, Johnsson E, Turesson I, Gullberg U, Hansson M, Nilsson B (Feb 2014). "Robust isolation of malignant plasma cells in multiple myeloma". Blood. 123 (9): 1336–40. doi:10.1182/blood-2013-09-529800. PMID 24385542.

Further reading

[edit]